Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Gadd45 family of proteins includes Gadd45alpha, MyD118/Gadd45beta, and CR6/OIG37/Gadd45gamma. These proteins play important roles in maintaining genomic stability and in regulating the cell cycle. This study reports the cloning of a novel protein called
CR6-interacting factor 1
(
CRIF1
) which interacts with Gadd45alpha, MyD118/Gadd45beta, and CR6/OIG37/Gadd45gamma.
CRIF1
binds specifically to the Gadd45 family proteins, as determined by an in vitro glutathione S-transferase pull-down assay and an in vivo mammalian cell two-hybrid assay along with coimmunoprecipitation assays.
CRIF1
mRNA is highly expressed in the thyroid gland, heart, lymph nodes, trachea, and adrenal tissues.
CRIF1
localizes exclusively to the nucleus and colocalizes with Gadd45gamma. Recombinant
CRIF1
inhibits the histone H1 kinase activity of immunoprecipitated Cdc2-cyclin B1 and
Cdk2
-cyclin E, and the inhibitory effects were additive with Gadd45 proteins. Overexpression of
CRIF1
increases the percentage of cells in G1, decreases the percentage of cells in S phase, and suppresses growth in NIH3T3 cells. The down-regulation of endogenous
CRIF1
by the transfection of the small interfering RNA duplexes resulted in the inactivation of Rb by phosphorylation and decreased the G1 phase cell populations. Expression of
CRIF1
is barely detectable in adrenal adenoma and papillary thyroid cancer and much lower than in adjacent normal tissue. The results presented here suggest that
CRIF1
is a novel nuclear protein that interacts with Gadd45 and may play a role in negative regulation of cell cycle progression and cell growth.
...
PMID:CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. 1271 9